Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes.
暂无分享,去创建一个
S. Rosenberg | P. Hwu | C. Smith | J. Mulé | S. Schwarz | M. Custer
[1] S. Rosenberg,et al. Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. , 1991, Journal of immunology.
[2] A. Asher,et al. Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors. , 1991, Journal of immunology.
[3] S. Rosenberg,et al. Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes , 1991, The Journal of experimental medicine.
[4] J. Cohen,et al. Optimal collection of blood samples for the measurement of tumor necrosis factor alpha. , 1990, Cytokine.
[5] K. Cornetta,et al. Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. , 1990, The New England journal of medicine.
[6] C. Smith,et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. , 1990, Science.
[7] G. Wong,et al. Molecular cloning and expression of a receptor for human tumor necrosis factor , 1990, Cell.
[8] Miller Ad,et al. Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .
[9] W. Linehan,et al. Experience with the Use of High‐Dose Interleukin‐2 in the Treatment of 652 Cancer Patients , 1989, Annals of surgery.
[10] S M Larson,et al. Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] K. Pfizenmaier,et al. Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies. , 1989, European journal of cancer & clinical oncology.
[12] D. Kufe,et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study. , 1988, Journal of the National Cancer Institute.
[13] R. Kurzrock,et al. A phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Kufe,et al. Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Tavernier,et al. EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER , 1987, The Lancet.
[16] S. Rosenberg,et al. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. , 1987, Journal of immunological methods.
[17] R. Smith,et al. The active form of tumor necrosis factor is a trimer. , 1987, The Journal of biological chemistry.
[18] A. Asher,et al. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. , 1987, Journal of immunology.
[19] W. Laird,et al. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. , 1986, Cancer research.
[20] J. Strickler,et al. Molecular cloning of the complementary DNA for human tumor necrosis factor. , 1985, Science.
[21] A. Sakurai,et al. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice , 1984, International journal of cancer.
[22] L. Old,et al. Partial purification of a serum factor that causes necrosis of tumors. , 1976, Proceedings of the National Academy of Sciences of the United States of America.
[23] R L Kassel,et al. An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.